Quinfamide
CAS No. 62265-68-3
Quinfamide ( WIN-40014 )
Catalog No. M26803 CAS No. 62265-68-3
Quinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 199 | Get Quote |
|
10MG | 285 | Get Quote |
|
25MG | 510 | Get Quote |
|
50MG | 732 | Get Quote |
|
100MG | 1017 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameQuinfamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
DescriptionQuinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
SynonymsWIN-40014
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIF-2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62265-68-3
-
Formula Weight354.2
-
Molecular FormulaC16H13Cl2NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC(Cl)C(=O)N1CCCc2cc(OC(=O)c3ccco3)ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xu R, et al. 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma. J Med Chem. 2019 Aug 8;62(15):6876-6893.
molnova catalog
related products
-
kuwanon G
Kuwanon G as dual inhibitors of PTP1B and α-glucosidase enzymes, as well as insulin sensitizers, it may potentially be utilized as an effective treatment for Type II diabetes mellitus.
-
DS-1040 tosylate
DS-1040 tosylate (DS1040)is a small molecule inhibitor of the activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50 of 1.7 ng/mL for rabbit TAFIa.
-
Copper(II) D-glucona...
Copper(II) D-gluconate powder in combination with silicon was used for the fabrication of carbon coated Si-Cu3Si composite as the anode materials for Li-ion batteries.